TANDEM DIABETES CARE INC. news, videos and press releases
For more news please use our advanced search feature.
TANDEM DIABETES CARE INC. - More news...
TANDEM DIABETES CARE INC. - More news...
- Tandem Diabetes Care to Announce First Quarter 2025 Financial Results on April 30, 2025
- Tandem Diabetes Care Announces NEJM Publication of Positive Pivotal Study Outcomes with Control-IQ+ AID Technology in Type 2 Diabetes
- Tandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the United States
- Tandem Diabetes Care Announces Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance
- Tandem Diabetes Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes
- Tandem Diabetes Care Announces Upcoming Conference Presentations
- Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025
- Tandem Diabetes Care Enters Multi-Year Research Collaboration with UVA Center for Diabetes Technology for Development of Advanced Insulin Delivery Systems
- Tandem t:slim X2 Insulin Pump Now Compatible with Dexcom G7 CGM in Canada
- Tandem Diabetes Care Announces Upcoming Conference Presentations
- TNDM DEADLINE ALERT: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action - TNDM
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM
- TNDM Investors Have Opportunity to Lead Tandem Diabetes Care, Inc. Securities Fraud Lawsuit
- SHAREHOLDER ALERT: Levi & Korsinsky Notifies Tandem Diabetes Care, Inc.(TNDM) Investors of a Class Action Lawsuit and Upcoming Deadline
- TNDM Investors Have Opportunity to Lead Tandem Diabetes Care, Inc. Securities Fraud Lawsuit
- SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Tandem Diabetes Care, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 7, 2023 - (NASDAQ: TNDM)
- DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm
- TNDM NOTICE: NATIONALLY RANKED ROSEN LAW FIRM Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action - TNDM
- UPCOMING DEADLINE ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm
- SHAREHOLDER ALERT: Levi & Korsinsky Notifies Tandem Diabetes Care, Inc.(TNDM) Investors of a Class Action Lawsuit and Upcoming Deadline
- TNDM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tandem Diabetes Care, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM
- TNDM Investors Have Opportunity to Lead Tandem Diabetes Care, Inc. Securities Fraud Lawsuit
- SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Tandem Diabetes Care, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 7, 2023 - (NASDAQ: TNDM)
- ROSEN, A TOP RANKED LAW FIRM, Encourages Tandem Diabetes Care, Inc. Investors with Losses to Secure Counsel Before Important November 7 Deadline in Securities Class Action - TNDM
- TNDM Investors Have Opportunity to Lead Tandem Diabetes Care, Inc. Securities Fraud Lawsuit
- SHAREHOLDER ALERT: Levi & Korsinsky Notifies Tandem Diabetes Care, Inc.(TNDM) Investors of a Class Action Lawsuit and Upcoming Deadline
- TNDM Investors Have Opportunity to Lead Tandem Diabetes Care, Inc. Securities Fraud Lawsuit
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM
